SCHEMBL20008492

SCHEMBL20008492

CC(F)(F)c1cc(C(N)=O)ccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KDM4B O94953 1/20 0.42
KDM5C P41229 1/20 0.42
KDM5B Q9UGL1 1/20 0.42
HTT P42858 1/20 0.40
SYK P43405 1/20 0.40
ALDH1A1 P00352 2/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 1/20 0.40
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
MYC P01106 1/20 0.39
RAF1 P04049 3/20 0.38
BRAF P15056 3/20 0.38
PARP1 P09874 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17526117 0.91 LMNA (0.44) LMNASMN1; SMN2NPC1RAB9AKDM4B
SCHEMBL4043325 0.86 LOXL2 (0.49) KDM4BKDM5CKDM5BSYKMKNK1
SCHEMBL29427234 0.86 LOXL2 (0.49) KDM4BKDM5CKDM5BSYKMKNK1
SCHEMBL11347447 0.86 LMNA (0.56) LMNASMN1; SMN2NPC1RAB9AKDM4B
SCHEMBL30893039 0.84 KDM4C (0.52) LMNASMN1; SMN2NPC1RAB9AKDM4B
SCHEMBL16036217 0.84 KDM4C (0.52) LMNASMN1; SMN2NPC1RAB9AKDM4B
Hydrochloric Acid SCHEMBL28122952 0.84 LOXL2 (0.50) KDM4BKDM5CKDM5BSYK
Formic Acid SCHEMBL29536942 0.80 SYK (0.44) KDM4BKDM5CKDM5BSYK
SCHEMBL22169023 0.80 ALDH1A1 (0.44) LMNASMN1; SMN2NPC1RAB9AKDM4B
SCHEMBL26132372 0.80 KDM4E (0.54) LMNASMN1; SMN2NPC1RAB9AKDM5C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3299367-A1 BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS Novartis AG (CH) 2018-03-28 EP disclosed